내시경 절제술 후 헬리코박터 파일로리 제균 치료 = Helicobacter pylori Eradication after Endoscopic Resection of Gastric Epithelial Neoplasms

다국어 초록 (Multilingual Abstract)

Endoscopic submucosal dissection is widely accepted as standard treatment for early gastric cancer; however, long-term management of metachronous gastric cancer after endoscopic resection is an important issue that is gaining much attention. Several prospective and retrospective studies have reported that Helicobacter pylori (H. pylori) eradication can reduce the risk of metachronous gastric cancer after endoscopic resection. Although there is lack of sufficient data regarding this subject, a few studies have reported histologically proven improvement in atrophic gastritis and intestinal metaplasia following H. pylori eradication in patients undergoing endoscopic resection. Therefore, treatment for H. pylori eradication should be considered in this patient population to reduce the incidence of metachronous gastric cancer and improve long-term outcomes.

참고문헌 (Reference)

1 Rokkas T, "The long-term impact of Helicobacter pylori eradication on gastric histology : a systematic review and meta-analysis" 12 (12): 32-38, 2007

2 Takagi T, "The influence of long-term use of proton pump inhibitors on the gut microbiota : an age-sex-matched case-control study" 62 : 100-105, 2018

3 "S chistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the evaluation of carcinogenic risks to humans. Lyon, 7-14 June 1994" 61 : 1-241, 1994

4 Hwang YJ, "Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication-a prospective study for up to 10 years" 47 : 380-390, 2018

5 Shiraev TP, "Proton pump inhibitors and cardiovascular events : a systematic review" 27 : 443-450, 2018

6 Kim YI, "Long-term survival after endoscopic resection versus surgery in early gastric cancers" 47 : 293-301, 2015

7 Mosholder AD, "Long-term risk of acute myocardial infarction, stroke, and death with outpatient use of clarithromycin : a retrospective cohort study" 187 : 786-792, 2018

8 Pyo JH, "Long-term outcome of endoscopic resection vs. surgery for early gastric cancer: a non-inferiority- matched cohort study" 111 : 240-249, 2016

9 Choi IJ, "Long-term outcome comparison of endoscopic resection and surgery in early gastric cancer meeting the absolute indication for endoscopic resection" 81 : 333-341.e1, 2015

10 Sang Gyun Kim, "Long-Term Clinical Outcomes of Endoscopic Submucosal Dissection in Patients with Early Gastric Cancer: A Prospective Multicenter Cohort Study" 거트앤리버 소화기연관학회협의회 12 (12): 402-410, 2018

11 Kong YJ, "Histological changes of gastric mucosa after Helicobacter pylori eradication : a systematic review and meta-analysis" 20 : 5903-5911, 2014

12 Choi IJ, "Helicobacter pylori therapy for the prevention of metachronous gastric cancer" 378 : 1085-1095, 2018

13 Xiao S, "Helicobacter pylori status and risks of metachronous recurrence after endoscopic resection of early gastric cancer : a systematic review and meta-analysis" 54 : 226-237, 2019

14 Wong BC, "Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China : a randomized controlled trial" 291 : 187-194, 2004

15 Chen HN, "Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia : evidence from a metaanalysis" 19 : 166-175, 2016

16 Biragyn A, "Gut dysbiosis : a potential link between increased cancer risk in ageing and inflammaging" 19 : e295-e304, 2018

17 Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries" 68 : 394-424, 2018

18 Wang J, "Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication : a meta-analysis" 83 : 253-260, 2011

19 Choi J, "Eradication of Helicobacter pylori after endoscopic resection of gastric tumors does not reduce incidence of metachronous gastric carcinoma" 12 : 793-800.e1, 2014

20 Ryu SJ, "Endoscopic submucosal dissection versus surgical resection for early gastric cancer : a retrospective multicenter study on immediate and long-term outcome over 5 years" 30 : 5283-5289, 2016

21 강기주, "Endoscopic Submucosal Dissection of Early Gastric Cancer" 거트앤리버 소화기연관학회협의회 5 (5): 418-426, 2011

22 김윤경, "Effects of Screening on Gastric Cancer Management: Comparative Analysis of the Results in 2006 and in 2011" 대한위암학회 14 (14): 129-134, 2014

23 Choi JM, "Effects of Helicobacter pylori eradication for metachronous gastric cancer prevention : a randomized controlled trial" 88 : 475-485.e2, 2018

24 Fukase K, "Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer : an open-label, randomised controlled trial" 372 : 392-397, 2008

25 Uemura N, "Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer" 6 : 639-642, 1997

26 Yoon SB, "Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors : a metaanalysis" 19 : 243-248, 2014

27 van der Hulst RW, "Effect of Helicobacter pylori eradication on gastritis in relation to cagA : a prospective 1-year follow-up study" 113 : 25-30, 1997

28 Young-Il Kim, "Effect of Helicobacter pylori Treatment on Long-term Mortality in Patients with Hypertension" 거트앤리버 소화기연관학회협의회 14 (14): 47-56, 2020

29 Wu CY, "Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease" 137 : 1641-1648.e1-e2, 2009

30 Gyawali B, "Does Helicobacter pylori eradication therapy to prevent gastric cancer increase all-cause mortality" 144 : 411-412, 2019

31 Bochao Zhao, "Does Helicobacter pylori Eradication Reduce the Incidence of Metachronous Gastric Cancer After Curative Endoscopic Resection of Early Gastric Cancer" Ovid Technologies (Wolters Kluwer Health) 54 (54): 235-241, 2019

32 Winkel P, "Clarithromycin for stable coronary heart disease increases all-cause and cardiovascular mortality and cerebrovascular morbidity over 10years in the CLARICOR randomised, blinded clinical trial" 182 : 459-465, 2015

33 Becattini S, "Antibiotic-induced changes in the intestinal microbiota and disease" 22 : 458-478, 2016

34 Correa P, "A human model of gastric carcinogenesis" 48 : 3554-3560, 1988